Rx Import Controls Included In Tauzin/Dingell Bioterrorism Bill
Executive Summary
The House Energy & Commerce Committee bioterrorism bill would increase controls on the importation of pharmaceuticals
You may also be interested in...
Rx Import-For-Export Is Among Issues Holding Up Bioterrorism/PDUFA Bill
Rx import controls are among the remaining issues that need to be reconciled in the bioterrorism/Prescription Drug User Fee Act conference legislation to complete a consensus bill by Memorial Day
Rx Import-For-Export Is Among Issues Holding Up Bioterrorism/PDUFA Bill
Rx import controls are among the remaining issues that need to be reconciled in the bioterrorism/Prescription Drug User Fee Act conference legislation to complete a consensus bill by Memorial Day
FDA’s 2002 Regulatory Agenda, In Brief
IRB registration: FDA to propose rule requiring institutional review boards to register with the agency. Registration information would include name of institution operating the IRB, detailed contact information for "the senior officer of the institution and IRB chair or contact, the range of active protocols...involving FDA-regulated products reviewed in previous calendar year, and a description of the types of...products reviewed." The rule is intended to "make it easier for FDA to inspect IRBs and to convey information to IRBs," HHS' Unified Agenda for 2002 explains. FDA is also endorsing a voluntary IRB accreditation system...